Charlie Knuth making strides in recoveryFox11online.comCharlie Knuth making strides in recovery. Updated: Tuesday, 04 Sep 2012, 8:04 AM CDT Published : Tuesday, 04 Sep 2012, 8:04 AM CDT. A Fox Valley boy diagnosed with a painful skin disease is making …
Breakfast to benefit woman with heart failure – Watauga Democrat
Breakfast to benefit woman with heart failureWatauga DemocratJessica Fournier, 27, was recently diagnosed with advanced heart failure, and the fundraiser will assist her and her family with the medical costs she is facing. The breakfast will include ho…
Stocks to Watch: Campbell Soup, Medicis Pharma, Questcor Pharma
Among the companies with shares expected to actively trade in Tuesday's session are Campbell Soup, Medicis Pharmaceutical and Questcor Pharmaceuticals.
Lack of evidence to recommend routine screening for chronic kidney disease – News-Medical.net
Lack of evidence to recommend routine screening for chronic kidney diseaseNews-Medical.netCurrently there is insufficient evidence to recommend the routine screening of chronic kidney disease (CKD) in asymptomatic adults in the general population, acco…
Literatus: Changing kidneys
EVEN an ending life can be prolonged, given the right science, the right technology and certainly the right kind of prayer. During the end-stage of renal disease (the point at which the condition of a kidney is a few steps toward failure) life can stil…
Facebook To Spread Organ Donor Initiative to Asia – WebProNews
Facebook To Spread Organ Donor Initiative to AsiaWebProNewsIt looks like South Korea will be the first Asian country that Facebook will tap in their ongoing organ donation awareness initiative. South Korean news site Yonhap is reporting that Facebook i…
Alnylam Pharma Reveal Phase IIb Trial With ALN-RSV01 Missed Primary Endpoint
Alnylam Pharma Reveal Phase IIb Trial With ALN-RSV01 Missed Primary Endpoint
ALNYLAM PHARMACEUTICALS, INC. : Alnylam Presents Complete Results … – 4-traders
ALNYLAM PHARMACEUTICALS, INC. : Alnylam Presents Complete Results …4-traders… 300,000 hospitalizations per year in the U.S. RSV infection in lung transplant patients represents an important unmet medical need. Lung transplant patients infected with…
Alnylam Presents Complete Results from Phase IIb Trial with ALN-RSV01, an Inhaled RNAi Therapeutic for the Treatment …
Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, announced today complete results from its Phase IIb trial with ALN-RSV01 for the treatment of respiratory syncytial virus infection in lung transplant patients.
Household chemicals can give you heart disease – Times of India
Household chemicals can give you heart diseaseTimes of IndiaIndiatimes|The Times of India|The Economic Times|. More. More. Follow. ADVERTISEMENT. The Times of India. Health. The Times of India. The Times of India Indiatimes Web (by Google) Video Photos…